Why the study?
Does the subcutaneous ICD effectively detect and convert ventricular tachyarrhythmias in patients requiring primary or secondary prevention of sudden cardiac death?
Does the subcutaneous ICD effectively detect and convert ventricular tachyarrhythmias in patients requiring primary or secondary prevention of sudden cardiac death?
While overall shock efficacy of the S-ICD is high, first-shock efficacy may be suboptimal, highlighting the need for careful patient selection and monitoring.
Answers are grounded in this paper and cite their sources.
First-shock S-ICD efficacy may be suboptimal; leaves open need for prospective optimization in sudden-death prevention.
Objectives: Recently, the subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of the S-ICD in a clinical setting. Methods: Between June 2010 and July 2011, 40 consecutive patients (42 ± 15 years; body mass index 27 ± 6 kg/m 2 ; left ventricular ejection fraction 47 ± 15%; 28 men) received an S-ICD for primary (n = 17) or secondary prevention (n = 23 [58%]) at three institutions in Germany. Intraoperative defibrillation efficacy testing failed in 1 patient with severely reduced left ventricular ejection fraction; testing was effective in all other patients. All episodes stored in the S-ICD were analyzed for appropriate and/or inappropriate detection as well as effective shock delivery to convert ventricular tachyarrhythmia into sinus rhythm. Results: During a median follow-up of 229 (interquartile range, 116 – 305) days, 4 patients experienced 21 episodes with correct detection of ventricular tachyarrhythmia and subsequent shock therapy. A total of 28 shocks were delivered in these 4 patients. Mixed logistic regression modeling revealed a shock efficacy of 96.4% (95% CI, 12.8% – 100%). The efficacy of first shocks, however, was only 57.9% (95% CI, 35.6% – 77.4%). Four episodes were incorrectly classified as ventricular tachyarrhythmia, which led to inappropriate shock delivery in 2 patients. Conclusions: Ineffective shock delivery may occur in patients with S-ICD, even after successful intraoperative testing. Multicenter trials are needed with close monitoring of safety and efficacy endpoints to identify patients who may be at risk for shock failure.
No takes yet. Share an insight, caveat, or question.
Sill et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: